January 2026
1. MILISAVLJEVIC J, Stosic M, Jovanovic N, Adzic Vukicevic T, et al
   Latent TB infection in solid organ transplant recipients in Serbia: A single center experience from a low TB burden country.
   PLoS One. 2026;21:e0339925.
   

   >> Share

   
   
2. WAKIYA T, Sanada Y, Okada N, Hirata Y, et al
   Data-driven predictive modeling for massive intraoperative blood loss during living donor liver transplantation: Integrating machine learning techniques.
   PLoS One. 2026;21:e0326000.
   

   >> Share

   
   
3. WANG G, Liu L, Zhang H, Mao P, et al
   Effects of tacrolimus treatment on the gut microbiota and metabolites in liver transplant recipients.
   PLoS One. 2026;21:e0343817.
   

   >> Share

   
   January 2025
4. SHOURABIZADEH H, Aleman DM, Rousseau LM, Zheng K, et al
   Classification-augmented survival estimation (CASE): A novel method for individualized long-term survival prediction with application to liver transplantation.
   PLoS One. 2025;20:e0315928.
   

   >> Share

   
   
5. OHIRA M, Imaoka Y, Sato K, Imaoka K, et al
   A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation.
   PLoS One. 2025;20:e0313102.
   

   >> Share

   
   
6. MIYAGAWA-HAYASHINO A, Imura T, Takezawa T, Hirai M, et al
   Activation of S1PR2 on macrophages and the hepatocyte S1PR2/RhoA/ROCK1/MLC2 pathway in vanishing bile duct syndrome.
   PLoS One. 2025;20:e0317568.
   

   >> Share

   
   
7. CHEN K, Yang M, Li G, Wang W, et al
   Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma: A systematic review and meta-analysis.
   PLoS One. 2025;20:e0317730.
   

   >> Share

   
   
8. DALMAU M, Charco R, Bilbao I, Dopazo C, et al
   Heparinase I treatment to overcome RNA quantification interference in heparinized liver donor samples: One size fits all?
   PLoS One. 2025;20:e0322899.
   

   >> Share

   
   
9. SLIFIRSKI H, Raykateeraroj N, Armellini A, Hazard R, et al
   Ultra-massive fluid transfusion in adult liver transplant recipients: A single center observational study.
   PLoS One. 2025;20:e0325829.
   

   >> Share

   
   
10. LIU L, Wang Q, Qin S, Su C, et al
    Comprehensive characterization of the competitive endogenous RNA network revealing its immune-related functions in hepatic ischemia-reperfusion injury.
    PLoS One. 2025;20:e0327101.
    

    >> Share

    
    
11. AL-HUSSAINI A, AlMannai M, Alruwaithi M, Faqeih E, et al
    Clinical and molecular characterization of hepatic glycogen storage disease in Saudi Arabia.
    PLoS One. 2025;20:e0329008.
    

    >> Share

    
    
12. SCHREINER AD, Zhang J, Gebregziabher M, Marsden J, et al
    The association of race with time to severe liver disease diagnoses.
    PLoS One. 2025;20:e0334016.
    

    >> Share

    
    
13. ALQAHTANI SA, AlMuhaidib S, Raptis DA, Al-Hamoudi WK, et al
    Metabolic dysfunction-associated steatohepatitis is the leading indication for adult liver transplantation in Saudi Arabia.
    PLoS One. 2025;20:e0338438.
    

    >> Share

    
    
14. LOPEZ-DIAZ G, Sanchez-Lorencio MI, Inarrairaegui M, Gonzalez-Dieguez ML, et al
    Longitudinal biomarker progression and validation for predicting operational tolerance in a prospective multicenter liver transplantation immunosuppression withdrawal trial.
    PLoS One. 2025;20:e0326442.
    

    >> Share

    
    January 2024
15. GITTUS M, Moore J, Ong ACM
    Liver transplant recipients with polycystic liver disease have longer waiting times but better long-term clinical outcomes than those with liver disease due to other causes: A retrospective cross-sectional study.
    PLoS One. 2024;19:e0294717.
    

    >> Share

    
    
16. LAUE T, Junge N, Leiskau C, Mutschler F, et al
    Diminished measles immunity after paediatric liver transplantation-A retrospective, single-centre, cross-sectional analysis.
    PLoS One. 2024;19:e0296653.
    

    >> Share

    
    
17. LIU W, Jiang D, Schulz M, Figueiredo C, et al
    Machine perfusion of the liver and in vivo animal models: A systematic review of the preclinical research landscape.
    PLoS One. 2024;19:e0297942.
    

    >> Share

    
    
18. AZAMAR-LLAMAS D, Arenas-Martinez JS, Olivas-Martinez A, Jimenez JV, et al
    Impact of COVID-19 vaccination on liver transplant recipients. Experience in a reference center in Mexico.
    PLoS One. 2024;19:e0301198.
    

    >> Share

    
    
19. WILSON EA, Woodbury A, Williams KM, Coopersmith CM, et al
    OXIDATIVE study: A pilot prospective observational cohort study protocol examining the influence of peri-reperfusion hyperoxemia and immune dysregulation on early allograft dysfunction after orthotopic liver transplantation.
    PLoS One. 2024;19:e0301281.
    

    >> Share

    
    
20. YUAN C, Li W, Liu J, Li J, et al
    Frailty and transplant-free survival of patients with liver cirrhosis: A meta-analysis.
    PLoS One. 2024;19:e0302836.
    

    >> Share

    
    
21. WEINBERG L, Caragata R, Hazard R, Ludski J, et al
    Venovenous bypass in adult liver transplant recipients: A single-center observational case series.
    PLoS One. 2024;19:e0303631.
    

    >> Share

    
    
22. WOLPERT BM, Rothgerber DJ, Rosner AK, Brunier M, et al
    Evaluation of dynamic cerebrovascular autoregulation during liver transplantation.
    PLoS One. 2024;19:e0305658.
    

    >> Share

    
    January 2023
23. LE FLOC'H B, Costet N, Vu N, Bernabeu-Gentey P, et al
    Involvement of circulating soluble HLA-G after liver transplantation in the low immunogenicity of hepatic allograft.
    PLoS One. 2023;18:e0282736.
    

    >> Share

    
    
24. CHO Y, Lee JE, Jeong H, Kwon JH, et al
    Cumulative postoperative change in serum albumin levels and organ failure after living-donor liver transplantation: A retrospective cohort analysis.
    PLoS One. 2023;18:e0285734.
    

    >> Share

    
    
25. FITZPATRICK E, Filippi C, Jagadisan B, Shivapatham D, et al
    Intraperitoneal transplant of Hepatocytes co-Encapsulated with mesenchymal stromal cells in modified alginate microbeads for the treatment of acute Liver failure in Pediatric patients (HELP)-An open-label, single-arm Simon's two stage phase 1 study pr
    PLoS One. 2023;18:e0288185.
    

    >> Share

    
    
26. KITAHARA J, Yoshinaga T, Kakihara S, Hirano T, et al
    Ocular findings in patients with acquired ATTRv amyloidosis following domino liver transplantation.
    PLoS One. 2023;18:e0291716.
    

    >> Share

    
    
27. MOON JJ, Hong SK, Kim YC, Hong SY, et al
    Soluble suppression of tumorigenicity 2 is a potential predictor of post-liver transplant renal outcomes.
    PLoS One. 2023;18:e0293844.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share